First-line immunotherapy treatment can improve survival for subset of lung cancer patients – The Cancer Letter Publications
|
First-line immunotherapy treatment can improve survival for subset of lung cancer patients
The Cancer Letter Publications Findings from a phase III clinical trial for advanced lung cancer patients could help oncologists better predict which patients are likely to receive the most benefit from immunotherapy as a first-line treatment based on the unique molecular … |
